These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23440340)

  • 21. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.
    Liu SY; Zheng PS
    Oncotarget; 2013 Dec; 4(12):2462-75. PubMed ID: 24318570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.
    Canino C; Mori F; Cambria A; Diamantini A; Germoni S; Alessandrini G; Borsellino G; Galati R; Battistini L; Blandino R; Facciolo F; Citro G; Strano S; Muti P; Blandino G; Cioce M
    Oncogene; 2012 Jun; 31(26):3148-63. PubMed ID: 22020330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
    Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
    Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
    Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
    Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
    Zhao R; Quaroni L; Casson AG
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.
    Raha D; Wilson TR; Peng J; Peterson D; Yue P; Evangelista M; Wilson C; Merchant M; Settleman J
    Cancer Res; 2014 Jul; 74(13):3579-90. PubMed ID: 24812274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.
    Pass HI; Lavilla C; Canino C; Goparaju C; Preiss J; Noreen S; Blandino G; Cioce M
    Oncotarget; 2016 Aug; 7(35):56408-56421. PubMed ID: 27486763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
    Zhang G; Ma L; Xie YK; Miao XB; Jin C
    Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disulfiram/copper targets stem cell-like ALDH
    Jin N; Zhu X; Cheng F; Zhang L
    J Cell Biochem; 2018 Aug; 119(8):6882-6893. PubMed ID: 29665144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.
    Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK
    Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
    Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
    Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
    Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
    Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma.
    Nguyen PH; Giraud J; Chambonnier L; Dubus P; Wittkop L; Belleannée G; Collet D; Soubeyran I; Evrard S; Rousseau B; Senant-Dugot N; Mégraud F; Mazurier F; Varon C
    Clin Cancer Res; 2017 Mar; 23(6):1586-1597. PubMed ID: 27620279
    [No Abstract]   [Full Text] [Related]  

  • 40. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
    Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.